Health insurer UnitedHealth Group unit OptumRx Corp agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth about $US12.8 billion.
Catamaran, formed from the merger of SXC Health Solutions and PBM Catalyst Health Solutions in 2012, helps the administrators of group healthcare plans reduce their prescription drug costs.
UnitedHealth’s offer of $US61.50 per share represents a premium of 27 per cent to Catamaran’s Friday close on the Nasdaq.
Catamaran’s stock was trading at $US60.50 premarket on Monday, while UnitedHealth’s was up nearly 3 per cent.
After the deal, UnitedHealth expects to fill more than one billion prescriptions, the companies said.
The deal value is based on Illinois-based Catamaran’s total outstanding diluted shares as of Dec. 31.
The transaction is expected to close in the fourth quarter of 2015 and add about 30 cents per share to UnitedHealth’s profit in 2016, the companies said.
(Reporting by Sneha Banerjee in Bengaluru; Editing by Savio D’Souza)
More from Reuters:
- Teva to buy U.S. drug developer Auspex Pharma for $US3.5 billion
- Taiwan seeks stronger cyber security ties with U.S. to counter China threat
- NJ man Christie told to ‘shut up’ to run for state Assembly
- Prosecution in Boston bombing trial seen wrapping case on Monday
- Students to fight gridlock at U.S. Senate simulator in Boston